---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-073116"
form_type: "8-K"
ticker: "NTLA"
cik: "0001652130"
company_name: "Intellia Therapeutics, Inc."
filed_at: "2024-06-13T23:59:59+00:00"
generated_at: "2026-06-01T04:37:47.942070+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Intellia shareholders approve officer liability limitation, re-elect directors at annual meeting

## Summary
- Stockholders approved amendment limiting officer liability under DGCL; 69M for, 2.9M against.
- Fred Cohen and Frank Verwiel re-elected as Class II directors with 65.4M and 55.8M votes for, respectively.
- Deloitte & Touche ratified as auditor for FY2024; 83.5M for, 256.7K against.
- Say-on-pay proposal passed with 70.4M for, 1.5M against.
- Certificate of Second Amendment filed with Delaware Secretary of State on June 12, 2024.

## SEC filing metadata
- accession: 0000950170-24-073116
- form_type: 8-K
- ticker: NTLA
- cik: 0001652130
- company_name: Intellia Therapeutics, Inc.
- filed_at: 2024-06-13T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.03, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1652130/000095017024073116/0000950170-24-073116-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1652130/000095017024073116/ntla-20240612.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-073116
- JSON: https://secwatch.observer/filing/0000950170-24-073116.json
- Plain text: https://secwatch.observer/filing/0000950170-24-073116.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.